 | • レポートコード：GIR201114994 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、レイノー病治療の世界市場を調査対象にし、レイノー病治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Allergan Plc、Covis Pharmaceuticals, Inc.、Apricus Biosciences, Inc.、Bayer AG、Human Stem Cells Institute ・企業別売上、市場シェア ・レイノー病治療の地域別市場分析 ・レイノー病治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・レイノー病治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・レイノー病治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・レイノー病治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・レイノー病治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・レイノー病治療の種類別市場規模2015-2020：アセチルシステイン、アルプロスタジル、ELS-140、ネオバスカルゲン、ニトログリセリン、その他 ・レイノー病治療の用途別市場規模2015-2020：病院、クリニック、その他 ・レイノー病治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Raynauds Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Raynauds Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Raynauds Disease Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Raynauds Disease Treatment market has been segmented into:
Acetylcysteine
Alprostadil
ELS-140
Neovasculgen
Nitroglycerin
Others
By Application, Raynauds Disease Treatment has been segmented into:
Hospital
Clinic
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Raynauds Disease Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Raynauds Disease Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Raynauds Disease Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Raynauds Disease Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Raynauds Disease Treatment Market Share Analysis
Raynauds Disease Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Raynauds Disease Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Raynauds Disease Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Raynauds Disease Treatment are:
Allergan Plc
Covis Pharmaceuticals, Inc.
Apricus Biosciences, Inc.
Bayer AG
Human Stem Cells Institute
Table of Contents
1 Raynauds Disease Treatment Market Overview
1.1 Product Overview and Scope of Raynauds Disease Treatment
1.2 Classification of Raynauds Disease Treatment by Type
1.2.1 Global Raynauds Disease Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Raynauds Disease Treatment Revenue Market Share by Type in 2019
1.2.3 Acetylcysteine
1.2.4 Alprostadil
1.2.5 ELS-140
1.2.6 Neovasculgen
1.2.7 Nitroglycerin
1.2.8 Others
1.3 Global Raynauds Disease Treatment Market by Application
1.3.1 Overview: Global Raynauds Disease Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Raynauds Disease Treatment Market by Regions
1.4.1 Global Raynauds Disease Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Raynauds Disease Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Raynauds Disease Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Raynauds Disease Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Raynauds Disease Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Raynauds Disease Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Raynauds Disease Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Allergan Plc
2.1.1 Allergan Plc Details
2.1.2 Allergan Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Allergan Plc SWOT Analysis
2.1.4 Allergan Plc Product and Services
2.1.5 Allergan Plc Raynauds Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Covis Pharmaceuticals, Inc.
2.2.1 Covis Pharmaceuticals, Inc. Details
2.2.2 Covis Pharmaceuticals, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Covis Pharmaceuticals, Inc. SWOT Analysis
2.2.4 Covis Pharmaceuticals, Inc. Product and Services
2.2.5 Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Apricus Biosciences, Inc.
2.3.1 Apricus Biosciences, Inc. Details
2.3.2 Apricus Biosciences, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Apricus Biosciences, Inc. SWOT Analysis
2.3.4 Apricus Biosciences, Inc. Product and Services
2.3.5 Apricus Biosciences, Inc. Raynauds Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bayer AG
2.4.1 Bayer AG Details
2.4.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bayer AG SWOT Analysis
2.4.4 Bayer AG Product and Services
2.4.5 Bayer AG Raynauds Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Human Stem Cells Institute
2.5.1 Human Stem Cells Institute Details
2.5.2 Human Stem Cells Institute Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Human Stem Cells Institute SWOT Analysis
2.5.4 Human Stem Cells Institute Product and Services
2.5.5 Human Stem Cells Institute Raynauds Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Raynauds Disease Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Raynauds Disease Treatment Players Market Share
3.2.2 Top 10 Raynauds Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Raynauds Disease Treatment Revenue and Market Share by Regions
4.2 North America Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
5 North America Raynauds Disease Treatment Revenue by Countries
5.1 North America Raynauds Disease Treatment Revenue by Countries (2015-2020)
5.2 USA Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
6 Europe Raynauds Disease Treatment Revenue by Countries
6.1 Europe Raynauds Disease Treatment Revenue by Countries (2015-2020)
6.2 Germany Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
6.4 France Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Raynauds Disease Treatment Revenue by Countries
7.1 Asia-Pacific Raynauds Disease Treatment Revenue by Countries (2015-2020)
7.2 China Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
7.5 India Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
8 South America Raynauds Disease Treatment Revenue by Countries
8.1 South America Raynauds Disease Treatment Revenue by Countries (2015-2020)
8.2 Brazil Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Raynauds Disease Treatment by Countries
9.1 Middle East & Africa Raynauds Disease Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Raynauds Disease Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Raynauds Disease Treatment Market Forecast by Type (2019-2024)
10.3 Acetylcysteine Revenue Growth Rate (2015-2025)
10.4 Alprostadil Revenue Growth Rate (2015-2025)
10.5 ELS-140 Revenue Growth Rate (2015-2025)
10.6 Neovasculgen Revenue Growth Rate (2015-2025)
10.7 Nitroglycerin Revenue Growth Rate (2015-2025)
10.8 Others Revenue Growth Rate (2015-2025)
11 Global Raynauds Disease Treatment Market Segment by Application
11.1 Global Raynauds Disease Treatment Revenue Market Share by Application (2015-2020)
11.2 Raynauds Disease Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Clinic Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Raynauds Disease Treatment Market Size Forecast (2021-2025)
12.1 Global Raynauds Disease Treatment Market Size Forecast (2021-2025)
12.2 Global Raynauds Disease Treatment Market Forecast by Regions (2021-2025)
12.3 North America Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
12.6 South America Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Raynauds Disease Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Raynauds Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Raynauds Disease Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Raynauds Disease Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Allergan Plc Corporate Information, Location and Competitors
Table 6. Allergan Plc Raynauds Disease Treatment Major Business
Table 7. Allergan Plc Raynauds Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Allergan Plc SWOT Analysis
Table 9. Allergan Plc Raynauds Disease Treatment Product and Solutions
Table 10. Allergan Plc Raynauds Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Covis Pharmaceuticals, Inc. Corporate Information, Location and Competitors
Table 12. Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Major Business
Table 13. Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Covis Pharmaceuticals, Inc. SWOT Analysis
Table 15. Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Product and Solutions
Table 16. Covis Pharmaceuticals, Inc. Raynauds Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Apricus Biosciences, Inc. Corporate Information, Location and Competitors
Table 18. Apricus Biosciences, Inc. Raynauds Disease Treatment Major Business
Table 19. Apricus Biosciences, Inc. Raynauds Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Apricus Biosciences, Inc. SWOT Analysis
Table 21. Apricus Biosciences, Inc. Raynauds Disease Treatment Product and Solutions
Table 22. Apricus Biosciences, Inc. Raynauds Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bayer AG Corporate Information, Location and Competitors
Table 24. Bayer AG Raynauds Disease Treatment Major Business
Table 25. Bayer AG Raynauds Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 26. Bayer AG SWOT Analysis
Table 27. Bayer AG Raynauds Disease Treatment Product and Solutions
Table 28. Bayer AG Raynauds Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Human Stem Cells Institute Corporate Information, Location and Competitors
Table 30. Human Stem Cells Institute Raynauds Disease Treatment Major Business
Table 31. Human Stem Cells Institute Raynauds Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Human Stem Cells Institute SWOT Analysis
Table 33. Human Stem Cells Institute Raynauds Disease Treatment Product and Solutions
Table 34. Human Stem Cells Institute Raynauds Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Global Raynauds Disease Treatment Revenue (Million USD) by Players (2015-2020)
Table 36. Global Raynauds Disease Treatment Revenue Share by Players (2015-2020)
Table 37. Global Raynauds Disease Treatment Revenue (Million USD) by Regions (2015-2020)
Table 38. Global Raynauds Disease Treatment Revenue Market Share by Regions (2015-2020)
Table 39. North America Raynauds Disease Treatment Revenue by Countries (2015-2020)
Table 40. North America Raynauds Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 41. Europe Raynauds Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 42. Asia-Pacific Raynauds Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 43. South America Raynauds Disease Treatment Revenue by Countries (2015-2020)
Table 44. South America Raynauds Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 45. Middle East and Africa Raynauds Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 46. Middle East and Africa Raynauds Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 47. Global Raynauds Disease Treatment Revenue (Million USD) by Type (2015-2020)
Table 48. Global Raynauds Disease Treatment Revenue Share by Type (2015-2020)
Table 49. Global Raynauds Disease Treatment Revenue Forecast by Type (2021-2025)
Table 50. Global Raynauds Disease Treatment Revenue by Application (2015-2020)
Table 51. Global Raynauds Disease Treatment Revenue Share by Application (2015-2020)
Table 52. Global Raynauds Disease Treatment Revenue Forecast by Application (2021-2025)
Table 53. Global Raynauds Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Raynauds Disease Treatment Picture
Figure 2. Global Raynauds Disease Treatment Revenue Market Share by Type in 2019
Figure 3. Acetylcysteine Picture
Figure 4. Alprostadil Picture
Figure 5. ELS-140 Picture
Figure 6. Neovasculgen Picture
Figure 7. Nitroglycerin Picture
Figure 8. Others Picture
Figure 9. Raynauds Disease Treatment Revenue Market Share by Application in 2019
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Raynauds Disease Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 14. North America Raynauds Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Europe Raynauds Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Asia-Pacific Raynauds Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. South America Raynauds Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Middle East and Africa Raynauds Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Raynauds Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Raynauds Disease Treatment Revenue Share by Players in 2019
Figure 21. Global Top 5 Players Raynauds Disease Treatment Revenue Market Share in 2019
Figure 22. Global Top 10 Players Raynauds Disease Treatment Revenue Market Share in 2019
Figure 23. Key Players Market Share Trend
Figure 24. Global Raynauds Disease Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 25. Global Raynauds Disease Treatment Revenue Market Share by Regions (2015-2020)
Figure 26. Global Raynauds Disease Treatment Revenue Market Share by Regions in 2018
Figure 27. North America Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 28. Europe Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 29. Asia-Pacific Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 30. South America Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Middle East and Africa Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 32. North America Raynauds Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. North America Raynauds Disease Treatment Revenue Market Share by Countries in 2019
Figure 34. USA Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 35. Canada Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 36. Mexico Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Europe Raynauds Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 38. Europe Raynauds Disease Treatment Revenue Market Share by Countries in 2019
Figure 39. Germany Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 40. UK Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 41. France Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Russia Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Italy Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Raynauds Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 45. Asia-Pacific Raynauds Disease Treatment Revenue Market Share by Countries in 2019
Figure 46. China Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 47. Japan Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 48. Korea Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 49. India Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Southeast Asia Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 51. South America Raynauds Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. South America Raynauds Disease Treatment Revenue Market Share by Countries in 2019
Figure 53. Brazil Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Argentina Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Middle East and Africa Raynauds Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 56. Middle East and Africa Raynauds Disease Treatment Revenue Market Share by Countries in 2019
Figure 57. Saudi Arabia Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 58. UAE Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 59. Egypt Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 60. South Africa Raynauds Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 61. Global Raynauds Disease Treatment Revenue Share by Type (2015-2020)
Figure 62. Global Raynauds Disease Treatment Revenue Share by Type in 2019
Figure 63. Global Raynauds Disease Treatment Market Share Forecast by Type (2021-2025)
Figure 64. Global Acetylcysteine Revenue Growth Rate (2015-2020)
Figure 65. Global Alprostadil Revenue Growth Rate (2015-2020)
Figure 66. Global ELS-140 Revenue Growth Rate (2015-2020)
Figure 67. Global Neovasculgen Revenue Growth Rate (2015-2020)
Figure 68. Global Nitroglycerin Revenue Growth Rate (2015-2020)
Figure 69. Global Others Revenue Growth Rate (2015-2020)
Figure 70. Global Raynauds Disease Treatment Revenue Share by Application (2015-2020)
Figure 71. Global Raynauds Disease Treatment Revenue Share by Application in 2019
Figure 72. Global Raynauds Disease Treatment Market Share Forecast by Application (2021-2025)
Figure 73. Global Hospital Revenue Growth Rate (2015-2020)
Figure 74. Global Clinic Revenue Growth Rate (2015-2020)
Figure 75. Global Others Revenue Growth Rate (2015-2020)
Figure 76. Global Raynauds Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 77. Global Raynauds Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 78. Global Raynauds Disease Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 79. North America Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
Figure 80. Europe Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
Figure 81. Asia-Pacific Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
Figure 82. South America Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
Figure 83. Middle East and Africa Raynauds Disease Treatment Revenue Market Forecast (2021-2025)
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
ポンペ病治療の世界市場 2020年 Market Overview The global Pompe Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1052.4 million by 2025, from USD 972.6 million in 2019. The Pompe Disease…- 人獣共通感染症治療の世界市場 2020年 Market Overview The global Zoonotic Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Zoonotic Disease T…
- 末期腎臓病治療の世界市場 2020年 Market Overview The global End-Stage Kidney Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The End-Stage …
- カナバン病治療薬の世界市場 2020年 Market Overview The global Canavan Disease Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Canavan Disease …
- ICAD（頭蓋内アテローム性動脈硬化症）病理の世界市場 2020年 Market Overview The ICAD (Intracranial Atherosclerotic Disease) Pathology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pl…